BRCA1 anticorps (N-Term)
Aperçu rapide pour BRCA1 anticorps (N-Term) (ABIN2212000)
Antigène
Voir toutes BRCA1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 442-462, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- BRCA1, NT (BRCA1, RNF53, Breast cancer type 1 susceptibility protein, RING finger protein 53)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- BRCA1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 442-462 amino acids from the N-terminal region of human BRCA1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- BRCA1 (Breast Cancer 1 (BRCA1))
-
Autre désignation
- BRCA1
-
NCBI Accession
- NP_009228, NP_009225
-
UniProt
- P38398
-
Pathways
- Cycle Cellulaire, Réparation de l'ADN, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus
Antigène
-